INTRODUCTION
The human immunodeficiency virus type 1 (HIV-1) nef gene is a major virulence determinant in primate lentivirus, is uniquely conserved in HIV-1, HIV-2 and simian immunodeficiency virus (SIV), and is important, but not essential, for virus replication in vivo (Kestler et al., 1991) . The nef gene is located at the 39 end of the viral genome, partially overlaps the 39-long terminal repeat (LTR), is expressed during HIV-1 infection, and often accounts for up to 80 % of HIV-1-specific RNA transcripts during the early stages of virus replication (Robert-Guroff et al., 1990) . A long-term non-progressor (LTNP) AIDS patient infected with HIV-1 with deletions in the nef gene and the 39-LTR has been reported (Deacon et al., 1995; Kirchhoff et al., 1995) . However, three of six members of the Sydney blood bank cohort harbouring nef-deleted viruses did progress to AIDS (Learmont et al., 1999) . Further study is needed to evaluate these conflicting data and establish the relationship between nef gene function and AIDS progression.
RNA interference (RNAi) is a defence mechanism against aberrant transcripts that may be produced during viral infection and transposon mobilization (Fire et al., 1998; Ketting et al., 1999; Tabara et al., 1999; Aravin et al., 2001; Baulcombe, 2001; Sijen & Plasterk, 2003) , and is becoming a powerful tool for development of therapeutic agents against specific pathogens such as HIV-1 (Jacque et al., 2002; Yamamoto et al., 2002; Brisibe et al., 2003; Das et al., 2004; Nishitsuji et al., 2004) . Small interfering RNAs (siRNAs) are short RNA duplexes that direct the degradation of homologous mRNA (Elbashir et al., 2001 ). In contrast, microRNAs (miRNAs) bind to the 39 untranslated regions (UTR) of mRNA producing translational repression with or without target degradation (Zeng et al., 2003; Yekta et al., 2004) . Mature miRNA (~25 nt in size) is produced by the processing of~70 nt precursor stem-loop hairpin RNAs (pre-miRNA) by Dicer (Lee et al., 2002 (Lee et al., , 2003 . Animal miRNAs are thought to bind to cognate DNA sites in 39-UTRs to produce RNA heteroduplexes that inhibit translation of target RNA by an unknown mechanism (Hobert, 2004) . On the other hand, Cullen et al. (1984) , earlier than a report by Fire et al. (1998) , reported that in avian leukosis viruses (ALVs) an extensive overlap between 59-and 39-LTRs reduced the ability of the downstream 39-LTR to act as an efficient promoter by interfering with initiation of transcription, a phenomenon designated transcriptional overlap interference. It has also been reported that cis expression of mutated F12-HIV-1 nef inhibits replication of the highly productive NL4-3-HIV-1 strain (D'Aloja et al., 1998; Olivetta et al., 2000) . Our previous studies have shown that defective variants of nef dsRNA containing the 39-LTR regions, isolated from LTNP AIDS patients, inhibited HIV-1 transcription (Yamamoto et al., 2002) . Furthermore, HIV-1 nef encoding miRNA, miR-N367, has been identified in HIV-1-infected cells (Omoto et al., 2004b) , but the detailed function of miR-N367 and its relation to promoter interference have not been elucidated. The results presented here show that miR-N367 can efficiently downregulate viral transcription through the U3 region negative responsive element (NRE), possibly indicating that HIV-1 may regulate its own transcription and replication by using miR-N367.
METHODS
Plasmid construction. The short hairpin RNA (shRNA)-expressing feline foamy virus (FFV)-based STYLE vector system has been described previously (Omoto et al., 2004b) . For construction of an miR-N367 (SF2 nef nt 379-449)-expressing plasmid, pSTYLE-miR-N367, sense A (59-ACTAGCTAGCATTGGCAGAATTACACACCAGGGCC-AGGGATCAGATATCCACTGACCTTTGGATGGTGCTTCAAGCTA-GTTTTTTCCGCGGGGAT-39) and antisense B (59-ATCCCCGCGG-AAAAAACTAGCTTGAAGCACCATCCAAAGGTCAGTGGATATCT-GATCCCTGGCCCTGGTGTGTAATTCTGCCAATGCTAGCTAGT-39) oligonucleotides containing NheI and SacII linker sequences (underlined) were annealed, digested with NheI and SacII and cloned into plasmid pH1 digested with NheI and SacII (pH1-miR-N367). For insertion of the human H1 promoter plus shRNAs fragment into plasmid pSKY3.0 (Hatama et al., 2001) , the fragment was PCRamplified by primers C (59-ACGCGTCGACTCATCCTGACTGACG-TCATCAACCCGCTCC-39) and D (59-TAATACGACTCACTATAG-GG-39). The amplified fragment was blunt-ended with T4 DNA polymerase, digested with SalI, and ligated into pSKY3.0 after digestion with SalI and HpaI (pSTYLE-miR-N367). Plasmid pSTYLE containing a shRNA expression cassette against the nef gene (pSTYLE-176, 190, 367) was described previously (Omoto et al., 2004b) .
Preparation of a full-length HIV-1 SF2 LTR-Luc plasmid (pLTR SF2 ) was described previously (Yamamoto et al., 2002) . For construction of pLTR SF2 deletion mutants, the LTR fragment was amplified by PCR with primers E (59-GGGGTACCGGGACTTTCCGCTGGGG-ACTTTCC-39) and F (59-CCGCTCGAGTGCTAGAGATTTTTCCA-ACACTGAC-39) using pLTR SF2 as template. The amplified fragments were digested with KpnI and XhoI and then ligated into a pGL3-Basic vector (Promega) that had been digested with KpnI and XhoI (pLTR SF2 -105). For preparation of pHILL(+) or (2) plasmids, the full-length SF2 nef fragment was amplified by PCR with primers G (59-GCTCTAGAATGGGTGGCAAGTGGTC-39) and H (59-GCTC-TAGATCAGCAGTCTTTGTAGTACTCC-39) using plasmid SF2 as template. After digestion with XbaI, the fragment was inserted into the pLTR SF2 , which had been digested with XbaI, in the (+) or (2) orientation. Preparation of pPFV/nef, pPFV LTR-Luc and pCD-Tat was described previously (Omoto et al., 2004a (Omoto et al., , 2004b .
Cells and vector production. Jurkat and MT-4 T cells were cultured in RPMI 1640 medium (Gibco) supplemented with 10 % fetal bovine serum (FBS) and antibiotics. For preparation of STYLE vectors, CRFK cells were grown in Iscove's Modified Dulbecco's Medium (Gibco) with 10 % FBS and antibiotics, and BHK cells were also grown in Dulbecco's modified Eagle Medium (Gibco) supplemented with 10 % FBS and antibiotics. The STYLE and PFV/nef vectors were prepared as described previously (Omoto et al., 2004b) .
Luciferase (Luc) assay. Jurkat T or MT-4 T cells were seeded at 2610 6 cells per well in 6-well plates. The next day, cells were transfected with 4 mg DNA and 6 ml DMRIE-C Reagent (Invitrogen) per well according to the manufacturer's instruction. For transfection with HIV-1 or PFV/nef-infected cells, each transfection mixture contained 3?6 mg reporter construct and 0?4 mg pCMVb. The experiments using pHILL reporter system were performed with 1 mg reporter plasmid, 2 mg pH1, 0?5 mg pCD-Tat and 0?5 mg pCMVb. At 48 h post-transfection, firefly Luc assays were performed as described previously (Yamamoto et al., 2002) .
Northern blot analysis. Total RNAs were extracted from PFV/nef, HIV-1 IIIB or mock-infected MT-4 T cells using TRIzol reagent (Invitrogen) . Approximately 40 mg total RNA was treated with or without RNase A and T1 (Sigma) as described previously (Yamamoto et al., 2002) , then subjected to electrophoresis on a 15 % polyacrylamide-7 M urea gel and electroblotted to Hybond-N + (Pharmacia) for 4 h at 400 mA. RNAs were immobilized by UV cross-linking and baking for 1 h at 80 uC. Hybridization was done with an ECL Direct kit (Pharmacia). The sequence for synthetic DNA probe is (59-TTGAAGCACCATCCAAAGGTCAGT-39).
RESULTS

Detection of miRNAs in HIV-1-infected cells and nef transduced cells
Epstein-Barr virus (EBV)-encoded miRNAs have been recently reported. To investigate miRNA expression in PFV/nef transduced and HIV-1 persistently infected T cells, cultured for 12 months and of which about 98 % cells were Env-positive as described previously (Kawai et al., 2003; Omoto et al., 2004b) , we extracted total RNA from PFV/nef-infected Jurkat T cells and carried out Northern blot analyses using probes for nef miR-N367. Analyses using an antisense miR-N367 probe detected small RNA molecules~25 nt in size (miR), putative precursor bands (miR-L) and PFV/nef major transcripts (12, 6, 4?1, 2?7 and 2?4 kb) (Fig. 1a) . The experiments using the miR-N367 probe were then carried out with total RNA from HIV-1 IIIB-infected MT-4 T cells. The miR~25 nt in size and miR-L were detected together with HIV-1 major transcripts (9?1, 4?3 and 1?8 kb) (Fig. 1b) . Similar results were obtained with total RNA from HIV-1 SF2 strain-infected MT-4 T cells (data not shown). RNA samples that were treated with a mixture of single-stranded RNA-specific RNases A and T1 retained the~25 nt RNAs, but the PFV/nef and HIV-1 major transcripts were not detected ( Fig. 1a and b) , indicating that the miR could be miRNAs.
Inhibition of viral transcription by RNAi
Mutations in the shRNA sense-strand might affect the unmutated 21 nt stem-loop (Miyagishi et al., 2004) . In addition, miRNA hairpins are more effective inhibitors of targeted gene expression than conventional shRNAs (Boden et al., 2004) . Therefore, we investigated whether HIV-1 nef miRNA, miR-N367, could reduce PFV/nef and HIV-1 transcription more effectively than nef shRNAs or not (Fig. 2 ). An shRNA against the egfp or luc gene (STYLE-siegfp or -luc) was used as a positive or negative control. The inhibitory effects of STYLE on PFV/nef transcription were evaluated by Luc assays in Jurkat T cells infected with PFV/nef. STYLE-transduced cells were cultured for 72 h followed by transfection with pPFV LTR-Luc and culture for another 48 h. STYLE-miR-N367 showed the greatest reduction of Luc activity compared with 190 and 367 (Fig. 2) .
The inhibitory effects of miR-N367 against HIV-1 transcription were evaluated by Luc assays in MT-4 T cells infected with HIV-1 IIIB. Cultivation of the STYLEtransduced cells for 72 h followed by transfection with the pLTR SF2 and culture for another 48 h showed that miR-N367 suppressed HIV-1 LTR-driven Luc activity compared with nef shRNAs and controls (Fig. 2) . These data suggested that nef shRNA has more potential to inhibit HIV-1 transcription than PFV/nef.
Suppression of HIV-1 LTR-driven transcription by miR-N367
A possible mechanism by which miR-N367 might reduce HIV-1 transcription is promoter interference, but whether this mechanism occurs remains to be determined, whereas the plant miRNAs have targets in the 59-UTR (Sunkar & Zhu, 2004) . Therefore, to determine the activity of miR-N367, we cloned miRNA into pHILL and screened for an antiviral effect. Jurkat T cells were transfected with pH1-miR-N367, pCD-Tat and an HIV-1 LTR-Luc plasmid with a full-length (pLTR SF2 ) or an NRE deletion in the U3 of the 59-LTR region (pLTR SF2 -105), and Luc assays were performed 48 h post-transfection (Fig. 3) . Expression of miR-N367 reduced transcriptional activity of full-length HIV-1 LTR containing NRE by about 40 %. However, transcriptional activity of the NRE-deleted LTR plasmid (pLTR SF2 -105) was not statistically affected by miR-N367 expression (Fig. 3) . To examine further the effect of miR-N367 on posttranscriptional control by nef at the 39-UTR, we constructed pHILL(+), which contains the nef gene downstream of the luc gene. As a negative control, we constructed pHILL(2), which contains the nef gene in an inverted orientation. Luc activity was reduced by about 60 % in pHILL(+) transfected cells compared with control pLTR SF2 transfected cells in the absence of miR-N367 (Fig. 3) . Expression of miR-N367 reduced Luc activity of pHILL(+) by about 80 %, although miR-N367 expression in pHILL(2) control cells did not significantly change the Luc activity. These data suggest that miR-N367 can suppress HIV-1 LTR promoter activity via NRE in the U3 of the 59-LTR and nef sequences located at the 39-UTR of targeted regions.
DISCUSSION
In these studies, we have shown that nef-derived miR-N367 was produced in HIV-1-infected and nef transduced cells. Furthermore, miR-N367 can downregulate HIV-1 transcription via the NRE of the 59-LTR U3 region and nef sequences at the 39-UTR. We found that miR-N367 suppresses gene expression at the transcriptional level, which is a different mechanism than a previous report of a posttranscriptional event via a dsRNA-induced silencing complex (RISC) (Brisibe et al., 2003) . Recent studies have shown that miRNAs and siRNAs can block mRNA expression by similar mechanisms (Zeng et al., 2003) , that siRNAs can function as miRNAs (Doench et al., 2003) , and that EBV-encoded miRNAs have been found (Pfeffer et al., 2004) . The results reported here are consistent with these observations and showed that miRNA from the 39-LTR can regulate viral transcription.
Promoter interference has been observed in retrovirus LTRs, the P L promoter of l phage, prokaryotic operons and yeast (Cullen et al., 1984) . The fact that miR-N367 can repress HIV-1 promoter activity may be one of the mechanisms of promoter interference in retroviruses. Small regulatory RNAs (sRNAs) abound in bacteria and these have intriguing similarities to animal miRNAs (Gottesman, 2002; Hobert, 2004) . Therefore, a small fraction of miRNA might be transported to the nucleus and gain access to target DNA sequences. Although further studies are needed to clarify the precise mechanisms of promoter interference, these results suggest that miRNAs produced in HIV-1-infected cells may efficiently downregulate HIV-1 transcription through both posttranscriptional pathway and transcriptional neo-pathway, causing low pathogenic infections to be latent.
We have also provided data on the inhibition of HIV-1 nef expression by an shRNA and miRNA expressing FV-based STYLE vector. The apathogenic FVs have proven to be an effective means of targeting various cell types (Hill et al., 1999) . HIV and lentivector-mediated transfer of an shRNA-expression cassette have been shown to result in efficient silencing of a target gene (Miyagishi et al., 2004) , and led to the conclusion that RNA viruses could not become a target for siRNAs, although the HIV vector had a deletion in the LTR of the U3 nef region. Our results showed retrovirus RNA was accessible to siRNA and miRNA. The target sites in the LTR may not form a tight secondary structure, according to the siRNA Target Finder website (http://www.ambion.com/techlib/misc/ siRNA_finder.html) (Vella et al., 2004) . Further, high expression levels of shRNAs in lentivectors were cytotoxic and not stable (Fish & Kruithof, 2004) . As mir-273 is also a rare miRNA in Caenorhabditis elegans and was not found by cDNA cloning (Grad et al., 2003) , small accumulations and miRNAs from the 39-LTR U3 might be predicted, from the results above, to maintain the persistent infection state.
